Co-Authors
This is a "connection" page, showing publications co-authored by Gianluca Ianiro and Antonio Gasbarrini.
Connection Strength
6.438
-
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial. Nutrients. 2019 Mar 27; 11(4).
Score: 0.815
-
Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018 Aug 12; 10(8).
Score: 0.781
-
Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium". Circulation. 2018 01 09; 137(2):213-214.
Score: 0.750
-
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. Dig Liver Dis. 2021 11; 53(11):1428-1432.
Score: 0.237
-
SARS-CoV-2 vaccines and donor recruitment for FMT. Lancet Gastroenterol Hepatol. 2021 04; 6(4):264-266.
Score: 0.232
-
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features. BMC Infect Dis. 2020 Oct 19; 20(1):775.
Score: 0.227
-
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis. 2020 12; 52(12):1390-1395.
Score: 0.226
-
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19. Aliment Pharmacol Ther. 2020 Sep; 52(5):902-903.
Score: 0.225
-
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020 09; 69(9):1555-1563.
Score: 0.223
-
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020 05; 5(5):430-432.
Score: 0.218
-
Antibiotic and Modulation of Microbiota: A New Paradigm? J Clin Gastroenterol. 2018 Nov/Dec; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S74-S77.
Score: 0.198
-
Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis. United European Gastroenterol J. 2018 Oct; 6(8):1232-1244.
Score: 0.193
-
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018 07; 48(2):152-159.
Score: 0.193
-
Helicobacter pylori in metabolic related diseases. Minerva Gastroenterol Dietol. 2018 Sep; 64(3):297-309.
Score: 0.190
-
Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter. 2017 Sep; 22 Suppl 1.
Score: 0.183
-
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply. Clin Microbiol Infect. 2017 11; 23(11):891.
Score: 0.179
-
The gut microbiota: its anatomy and physiology over a lifetime. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):329-336.
Score: 0.178
-
Ipilimumab Adjuvant Therapy in Melanoma. N Engl J Med. 2017 01 26; 376(4):398.
Score: 0.175
-
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017 May; 23(5):337.e1-337.e3.
Score: 0.175
-
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13072-13088.
Score: 0.057
-
Letter: liver involvement and mortality in COVID-19 patients - authors' reply. Aliment Pharmacol Ther. 2020 Oct; 52(7):1264-1265.
Score: 0.057
-
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig Liver Dis. 2020 12; 52(12):1383-1389.
Score: 0.056
-
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020 08 20; 26(9):1306-1314.
Score: 0.056
-
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Aliment Pharmacol Ther. 2020 09; 52(6):1060-1068.
Score: 0.056
-
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
Score: 0.056
-
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer. Int J Mol Sci. 2019 Jan 24; 20(3).
Score: 0.050
-
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center. Int J Infect Dis. 2019 Mar; 80:105-110.
Score: 0.050
-
Wheat desensitization treatment in patients with gluten sensitivity. Postepy Dermatol Alergol. 2018 Jun; 35(3):320-322.
Score: 0.048
-
Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections. Front Microbiol. 2018; 9:675.
Score: 0.048
-
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. Drugs Today (Barc). 2018 Feb; 54(2):123-136.
Score: 0.047
-
Fecal microbiota transplantation: past, present and future perspectives. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):420-430.
Score: 0.047
-
The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int J Mol Sci. 2017 Sep 21; 18(10).
Score: 0.046
-
Faecal microbiota transplantation in clinical practice. Gut. 2018 01; 67(1):196-197.
Score: 0.044
-
Gut microbiota and inflammatory bowel disease: so far so gut! Minerva Gastroenterol Dietol. 2017 Dec; 63(4):373-384.
Score: 0.044
-
European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017 04; 66(4):569-580.
Score: 0.044
-
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives. Mediators Inflamm. 2013; 2013:391473.
Score: 0.034